AIHealthcare Analytics

Knowledge Wiki

Wiki › Full-Spectrum Generative Lead Discovery (FSGLD) — DRUG-GAN for Drug Discovery

Full-Spectrum Generative Lead Discovery (FSGLD) — DRUG-GAN for Drug Discovery

CONCEPT
Rev 1 Oct 29, 2026 04:12 UTC 1 sources

The Full-Spectrum Generative Lead Discovery (FSGLD) pipeline integrates deep learning-driven generative modeling with molecular docking, dynamics simulations, ligand-residue interaction profiling, MM-PBSA calculations, thermodynamic integration, and experimental validation. The core multiscale DRUG-GAN models enable guided discovery of drug-like, target-specific compounds by bridging theoretical design with practical application. This approach represents a maturation of AI-driven drug discovery beyond sequence generation, incorporating physics-based validation, binding affinity prediction, and pharmacophore optimization. The pipeline's integration of experimental validation loops addresses a critical gap in AI drug discovery: the need to validate computational predictions in wet-lab settings before clinical translation. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index